NPR’s All Things Considered on Tuesday examined the efforts of the British company Oxitec to develop a genetically modified mosquito meant to wipe out wild populations of the insects, which carry potentially lethal diseases such as dengue.

Genetically modified male mosquitoes are released into the wild to breed with females, and their offspring are designed to die. “Field trials in the Cayman Islands last year appeared to show it works. Oxitec released its genetically modified males, and, [Oxitec Chief Scientific Officer Luke] Alphey says, the population dropped by a whopping 80 percent,” NPR reports. However, some are opposed to the possible unintended consequences of releasing genetically modified insects into the wild, and regulators worldwide “are struggling to come up with rules and safeguards,” according to NPR (Brumfiel, 7/5).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.